{
    "title": "Novartis income edges higher on strong Sandoz, Entresto",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10753819/Novartis-earnings-edge-higher-Cosentyx-Entresto-sales.html",
    "date": "2022-04-26",
    "keywords": [
        "tuesday",
        "income",
        "burger",
        "quarter",
        "core",
        "rebound",
        "sandoz",
        "treatment",
        "growth",
        "market",
        "sale",
        "ceo",
        "unit",
        "surge",
        "heart",
        "failure",
        "analyst",
        "estimate",
        "arthritis",
        "psoriasis",
        "cosentyx",
        "revenue",
        "entresto",
        "consensus",
        "maker",
        "gain",
        "drugmaker",
        "update",
        "review",
        "yearend",
        "novartis",
        "stake",
        "roche",
        "rival",
        "worth",
        "spending",
        "power",
        "price",
        "tag",
        "executive",
        "vas",
        "narasimhan",
        "money",
        "call",
        "size",
        "biotech",
        "adjustment",
        "time",
        "month",
        "structure",
        "staff",
        "digit",
        "miranda",
        "murray",
        "vinay",
        "dwivedi",
        "alexander",
        "smith"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}